AGC
Aspen Grove Capital’s AstraZeneca AZN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $449K | Buy |
6,420
+564
| +10% | +$39.4K | 0.08% | 124 |
|
|
2025
Q1 | $430K | Buy |
5,856
+2,496
| +74% | +$183K | 0.08% | 124 |
|
|
2024
Q4 | $220K | Sell |
3,360
-2,917
| -46% | -$191K | 0.05% | 182 |
|
|
2024
Q3 | $489K | Buy |
6,277
+290
| +5% | +$22.6K | 0.11% | 102 |
|
|
2024
Q2 | $467K | Buy |
5,987
+648
| +12% | +$50.5K | 0.11% | 106 |
|
|
2024
Q1 | $362K | Buy |
5,339
+52
| +1% | +$3.52K | 0.1% | 122 |
|
|
2023
Q4 | $347K | Buy |
5,287
+71
| +1% | +$4.65K | 0.11% | 111 |
|
|
2023
Q3 | $353K | Buy |
5,216
+1,716
| +49% | +$116K | 0.13% | 105 |
|
|
2023
Q2 | $250K | Buy |
+3,500
| New | +$250K | 0.08% | 162 |
|
|
2023
Q1 | – | Sell |
-4,427
| Closed | -$300K | – | 157 |
|
|
2022
Q4 | $300K | Buy |
+4,427
| New | +$300K | 0.14% | 112 |
|